Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00852761Phase 4Completed
Phase 4, randomised, open-label trial of clobetasol in plaque psoriasis (2 arms), sponsored by GSK. Primary endpoint: At Least a One Grade Improvement for the Target Psoriasis Lesion on the Elbow or Knee (Psoriasis Grading Scale) at Day 15. Started Mar 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00852761.